Home > Specialists > Integrative Oncology > Dr. Bing Hu (胡兵)
Specialty & Clinical Focus:
Integrative oncology specialist at Longhua Hospital, Shanghai University of Traditional Chinese Medicine, with a clinical focus on comprehensive cancer care for solid tumors, stabilizing the tumor microenvironment, and mitigating the toxicity of conventional treatments.
Professional Title & Qualifications:
-
Chief Physician (Department of Oncology),
-
Professor & Doctoral Supervisor,
-
Ph.D. in Medicine
Hospital & Department：
Longhua Hospital, Shanghai University of Traditional Chinese Medicine - Department of Oncology (A National Clinical Research Center for TCM)
(address: No. 725 South Wanping Road, Xuhui District, Shanghai, 200032)
Dr. Bing Hu (胡兵) - Specialist in Integrative Oncology & TCM
Personal Biography
Dr. Bing Hu is an integrative oncology specialist at Longhua Hospital in Shanghai, with over 30 years of clinical and research experience. He specializes in the management of solid tumors by harmonizing modern Western oncology with Traditional Chinese Medicine (TCM). As a Chief Physician and doctoral supervisor, his clinical focus involves enhancing the patient's biological terrain to stabilize the tumor microenvironment. His integrative protocols are designed to support international patients managing complex malignancies, aiming to improve treatment tolerance and mitigate the toxicities of conventional therapies.
Why Choose Dr. Bing Hu for Integrative Oncology?
Dr. Bing Hu brings over three decades of clinical experience in integrative oncology, combining modern Western oncology with Traditional Chinese Medicine (TCM). His specialized approach focuses on stabilizing the tumor microenvironment and supporting the patient's overall biological terrain to help manage cancer progression. This dual methodology is designed to enhance the efficacy of conventional treatments like chemotherapy and radiotherapy while mitigating their associated toxicities.
As a Chief Physician and doctoral supervisor with an extensive research background, his practice is grounded in rigorous scientific evaluation. He offers targeted integrative protocols for a wide spectrum of complex malignancies, including gastrointestinal, thoracic, hepatic, and reproductive system cancers. By choosing Dr. Hu, international patients gain access to evidence-based comprehensive cancer care formulated by a senior specialist at a National Clinical Research Center for TCM.
Pre-Travel Case Review & Specialist Liaison
Navigating international medical travel for complex oncology care requires careful planning and informed decision-making. Before committing to a journey to China, global patients can request MedBridgeNZ coordination for a remote specialist-review pathway. Through this process, we assist with medical record preparation, translation coordination, and secure document transfer to Longhua Hospital.
Once prepared, Dr. Hu's office will review your submitted medical history to determine if his integrative oncology protocols align with your specific clinical needs. This allows you to receive a clear, objective specialist opinion from home, establishing administrative and travel feasibility before our team coordinates your in-person hospital appointments, medical visas, and non-clinical bilingual administrative support.
Disclaimer: MedBridgeNZ is a medical concierge provider serving a global client base. We assist with logistical coordination and facilitate access to healthcare professionals. MedBridgeNZ does not provide medical advice, diagnoses, or treatments.Any clinical feedback, treatment planning or suitability discussion remains with the relevant hospital or licensed specialist.
Secure a Remote Case Review with
Dr. Bing Hu
Areas of Expertise
Comprehensive Cancer Care: Integrative treatment for lung, gastric, colorectal, and breast cancers.
Synergy Therapy: Utilizing TCM to boost the efficacy of chemotherapy and radiotherapy while significantly reducing toxicity.
Advanced Metastasis Control: Specialized TCM protocols designed to stabilize the tumor microenvironment and prevent secondary spread.
Quality of Life Enhancement: Tailored herbal prescriptions to manage cancer-related pain, fatigue, and immune suppression.
Verified Client Satisfaction Metrics
⭐⭐⭐⭐⭐ 5.0/5.0 Overall Rating
* Treatment Pathway Satisfaction:
5.0/5.0
* Communication & Professionalism:
5.0/5.0
* High demand: Chosen online for specialist liaison and case reviews by over:
7,200 clients
(Source: These third-party platform indicators are provided for general reference only. They may change over time and should not be interpreted as a guarantee of diagnosis, treatment suitability, appointment availability, or individual clinical outcome.)
Work Experience
Senior Consultant & Chief Physician: Over 25 years of clinical excellence at Longhua Hospital, Shanghai.
Academic Leadership: Lead researcher for multiple National Natural Science Foundation of China (NSFC) projects.
International Consultant: Advisory role for international patients navigating Chinese integrative medicine through medical concierge services.
Education & Training
Awards & Honors
Shanghai Science and Technology Progress Award (Multiple recipient).
Outstanding TCM Clinician of China (National recognition).
Distinguished Doctoral Mentor Award for excellence in medical education.
Academic & Professional Memberships
Vice Chairman: Oncology Professional Committee, Shanghai Association of Traditional Chinese Medicine.
Standing Committee Member: Chinese Anti-Cancer Association (CACA), Integrative Medicine Division.
Executive Member: China Association of Chinese Medicine (CACM) Oncology Committee.
Research & Publications
Published 100+ peer-reviewed papers in international SCI-indexed and core Chinese medical journals.
Principal Investigator for multiple high-level state research grants focusing on molecular oncology.
Chief Editor of several definitive textbooks on TCM Oncology and Integrative Treatment.
Selected Peer-Reviewed Publications
Hu B, et al. Teng-Long-Bu-Zhong-Tang induces p21-dependent cell senescence in colorectal carcinoma LS174T cells via histone acetylation. J Exp Pharmacol. 2017;9:67-72. 👉 Read on PubMed (PMID: 28572741)
Hu B, et al. Traditional Chinese medicine formulation Yanggan Jiedu Sanjie inhibits TGF-β1-induced epithelial-mesenchymal transition and metastatic potential in human hepatocarcinoma Bel-7402 cells. BMC Complement Altern Med. 2019;19(1):67. 👉 Read on PubMed (PMID: 30876428)
Hu B, et al. Preventive and Therapeutic Effects of Chinese Herbal Compounds against Hepatocellular Carcinoma. Molecules. 2016;21(2):142. 👉 Read on PubMed (PMID: 26828466)
*The doctor’s information is sourced from the hospital’s official website or provided directly by the doctor. Due to update cycles, there may be occasional delays in reflecting the most recent changes.
Frequently Asked Questions (FAQs)
Is Dr. Hu's integrative approach suitable for my specific type of cancer?
Dr. Hu has clinical expertise in addressing a broad range of solid tumors and hematological malignancies, including lung, breast, gastrointestinal, and head and neck cancers. To determine if his specific therapies are clinically appropriate for your current diagnosis, we recommend starting with a remote specialist review. MedBridgeNZ coordinates the translation and secure transfer of your medical records so Dr. Hu can assess your case directly, providing clarity before you make travel decisions.
How can I initiate a case review with Dr. Hu if I am outside of China?
You do not need to travel immediately to receive an initial evaluation. MedBridgeNZ coordinates the administrative preparation and appointment communication required for a remote specialist review from your home country. As your dedicated medical concierge, we handle the logistics of this remote pathway, helping to establish administrative and clinical feasibility before you commit to international medical travel.
If I proceed with a hospital visit in China, how do I manage the logistics?
MedBridgeNZ manages the logistical framework of your medical journey. While we do not provide medical advice, our concierge team will assist with medical invitation and visa-document coordination support, travel arrangements, and coordinating in-person hospital appointment requests. We also provide non-clinical bilingual administrative support during your visits to Longhua Hospital to ensure clear communication with the medical team.
What exactly does an "integrative oncology" treatment plan involve?
Integrative oncology systematically combines standard Western medical treatments, such as chemotherapy, with evidence-based Traditional Chinese Medicine (TCM). Dr. Hu utilizes customized protocols aimed at managing cancer-related pain, reducing treatment toxicity, and supporting immune function. Based on the remote review of your records, Dr. Hu will outline how these complementary modalities might be applied to your specific clinical profile.
Flexible Ways to Connect with the Specialist
We understand that every client’s situation is unique. Beyond the Remote Written Review, we offer a range of flexible ways to access specialist insights:
-
Remote Video Liaison: For a more personal interaction, we can arrange a live video session, allowing you to discuss your case directly with the specialist with the help of our professional medical translators.
-
On-Site Proxy Liaison: If you cannot travel, our dedicated bilingual team can visit the hospital in person on your behalf. We will present your translated medical records to the specialist, facilitate your inquiries, and provide you with a comprehensive translated report of the doctor’s findings.
-
In-Person Appointment Booking: If you are planning to travel to China for treatment, we manage the complex hospital registration and appointment process, ensuring you have confirmed access to your chosen specialist upon arrival.
How MedBridgeNZ Helps You:
MedBridgeNZ is a medical concierge and logistics coordination provider for international patients seeking specialist-care pathways in China. We assist with appointment request coordination, medical-record preparation, translation coordination, visa-document coordination support, and non-clinical bilingual administrative support. We do not provide medical advice, diagnosis, or treatment. Third-party medical or travel costs remain separate unless expressly stated in writing.